Exploring Maternal Mental Health and Neonatal Risks in SSRI Study – AJOG MFM
American Journal of Obstetrics and Gynecology MFM – AJOG MFM shared a post on LinkedIn:
” In a large national cohort from Finland (over 1.2 million births), SSRI exposure was linked to:
- Lower risks of very preterm birth and low birth weight
- Higher risk of neonatal adaptation symptoms (eg, breathing problems, low 5-minute Apgar, neonatal care)
- Persistent increased risk of gestational diabetes
Takeaway: SSRI use during pregnancy has complex, independent effects — balancing maternal mental health benefits with neonatal adaptation considerations.
Read the full text to learn more.”
Proceed to the video attached to the post.
Title: SSRI use during pregnancy and maternal depression – a nationwide birth cohort study on risks to the mother and the newborn
Authors: Heli Malm, Alan S. Brown, Keely Cheslack-Postava, Mika Gissler, David Gyllenberg, Emmi Heinonen, Susanna Hinkka-Yli-Salomäki, Ian W. McKeague, Aleksi Tornio, Subina Upadhyaya, Andre Sourander
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 15, 2026, 12:21Zara Grigoryan: Open Expert Dialogue to Shape Women’s Health in Armenia
-
Jun 15, 2026, 12:12Abhishek Saxena։ Can a 5PN Embryo Develop Normally?
-
Jun 15, 2026, 12:02Does Growth Hormone Help in IVF? – Fertility Plus
-
Jun 15, 2026, 11:55Allen Morgan: PRP in Fertility Treatment, Emerging Evidence and Future Directions
-
Jun 15, 2026, 11:49Hereditary Gynecologic Cancer Care Is Evolving, but Access and Health Systems Remain Unequal – IJGO
-
Jun 15, 2026, 11:41Celebrating Community and Support at the Annual Fertili’Tea Party! – CFAS
-
Jun 15, 2026, 11:37Christopher Robinson: Outcomes in Late Preterm and Term Births with Gestational Diabetes vs Normoglycemia
-
Jun 15, 2026, 11:34Registration Now Open for Fertility 2027 – British Fertility Society
-
Jun 15, 2026, 11:28Ioakeim Sapantzoglou: Excited to Share Our Latest Publication in Archives of Gynecology and Obstetrics!